
FDA Greenlights Leucovorin for Autism-Related Neuropsychiatric Symptoms
Published on: Sept. 24, 2025, 1:21 a.m. | Source: Devdiscourse
The FDA has approved leucovorin, also known as folinic acid, for managing symptoms related to autism. The approval comes amid data on its efficacy for cerebral folate deficiency, associated with autism. Previously marketed as Wellcovorin, it was withdrawn not due to safety issues but business reasons.